Thyroid and hemostasis;Tiroide ed emostasi

Recenti Progressi in Medicina

Volumn 97, Issue 5, 2006, Pages 267-271

  Franchini, Massimo ^a,b  

^a Azienda Ospedaliera   (Italy)

^b OSPEDALE POLICLINICO   (Italy)

Author keywords

Bleeding; Hemostasis; Hyperthyroidism; Hypothyroidism; Thrombosis; Thyroid

Indexed keywords

BLOOD CLOTTING FACTOR; THYROID HORMONE;

BLEEDING; BLOOD CLOTTING DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTHYROIDISM; HYPOTHYROIDISM; PROTEIN SYNTHESIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS; THYROID DISEASE;

BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; HEMORRHAGE; HEMOSTASIS; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; THROMBOSIS; THYROID GLAND;

EID: 33745432596     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Simone JV, Abildgaard CF, Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med 1965; 273: 1057-61.
2. Franchini M. Hemostasis and thyroid diseases revisited. J Endocrinol Invest 2004; 27: 886-92.
3. Marongiu F, Cauli C, Mariotti S. Thyroid, hemostasis and thrombosis. J Endocrinol Invest 2004; 27: 1065-71.
4. Ford HC, Carter JM. Haemostasis in hypothyroidism. Postgrad Med J 1990; 66: 280-84.
5. Erem C, Kavgaci H, Ersöz H, et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 2003; 57: 78-81.
6. Savage RA, Sipple C. Marrow myxedema. Arch Pathol Lab Med 1975; 111: 375-7.
7. Berchtold P, Harris JP, Tani P, Piro L, McMillan R. Autoantibodies to platelet glycoproteins in patients with disease-related immune thrombocytopenia. Br J Haematol 1989; 73: 365-8.
8. Hofbauer LC, Spitzweg C, Schmauss S, Heufelder AE. Graves disease associated with autoimmune thrombocytopenic purpura. Arch Intern Med 1997; 157:1033-6.
9. Edson JR, Fecher DR, Doe RP. Low platelet adhesiveness and other abnormalities in hypothyroidism. Ann Intern Med 1975; 82: 342-6.
10. Palareti G, Biagi G, Legnani C, et al. Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy. Thromb Haemost 1989; 62: 1053-6.
11. Myrup B, Bregengård C, Faber J. Primary haemostasis and thyroid disease. J Int Med 1995; 238: 59-63.
12. Smith SR, Anger MJ. Hypothyroidism and von Willebrand's disease. Lancet 1987; 1: 1314.
13. Michiels JJ, Sehroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001; 7: 113-5.
14. Franchini M, de Gironcoli M, Lippi G, et al. Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery. Haematologica 2002; 8: 142-4.
15. Attivissimo LA, Lichtman SM, Klein I. Acquired von Willebrand's syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism. Thyroid 1995; 5: 399-401.
16. Aylesworth C, Smallridge RC, Rick ME, Alving BM. Acquired von Willebrand's disease: a rare manifestation of postpartum thyroiditis. Am J Hematol 1995; 50: 217-9.
17. Franchini M, Veneri D, Lippi G. Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels. Thromb Haemost 2005; 93: 392-3.
18. Meiklejohn DJ, Watson HG. Acquired haemophilia in association with organ-specific autoimmune disease. Haemophilia 2001; 7: 523-5.
19. Graninger W, Pirich KR, Speiser W, Deutsch E, Waldhäusl WK. Effect of thyroid hormones on plasma protein concentration in man. J Clin Endocrinol Metab 1986; 63: 407-11.
20. Van Oosterom AT, Kerkhoven P, Veltkamp JJ. Metabolism of the coagulation factors of the prothrombin complex in hypothyroidism in man. Thromb Haemost 1979; 41: 273-85.
21. De Feo P. Hormonal regulation of human protein metabolism. Eur J Endocrinol 1996; 135: 7-18.
22. Egeberg BO. Influence of thyroid function on the blood clotting system. Scand J Clin Lab Invest 1963; 15: 1-7.
23. Nordoy A, Vikmo H, Berntsen H. Haemostatic and lipid abnormalities in hypothyroidism. Scand J Haematol 1976; 16: 154-60.
24. Marongiu F, Conti M, Murtas ML, Mameli G, Sorano GG, Martino E. Activation of blood coagulation in Graves' disease. Horm Metab Res 1991; 23: 609-11.
25. 3 on platelet kinetics. Acta Haematol 1980; 63: 185-90.
26. 111Indium labeled platelet kinetics and platelet associated immunoglobulins G and M. J Clin Endocrinol Metab 1990; 70: 491-6.
27. Cordiano I, Betterle C, Spadaccino CA, Soini B, Girolami A, Fabris F. Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin Exp Immunol 1998; 113: 373-8.
28. Marongiu F, Cauli C, Mameli G, Usai B, Mariotti S. Apatehtic Graves' disease and acquired hemophilia due to factor VIIIc antibody. J Endocrinol Invest 2002; 25: 246-9.
29. Rosen IB, Anderson I, Musclow CE. The factor of factor XI deficiency in thyroid neoplasia. Surgery 1986; 100: 1062-7.
30. Müller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA. Haemostatic profile in hypothyroidism as potential risk for vascular or thrombotic disease. Eur J Clin Invest 2001; 31: 131-7.
31. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 2000; 132: 270-8.
32. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 2001; 86: 732-7.
33. Chadarevian R, Jublanc C, Bruckert E, et al. Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism. J Endocrinol Invest 2005; 28: 398-404.
34. Özcan MA, Çömlekçi A, Demrkan F, et al. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thromb Res 2003; 110: 243-7.
35. Marongiu F, Conti M, Murtas ML, et al. Anticardiolipin antibodies in Grave's disease: relationship with thrombin activity in vivo. Thromb Res 1991; 64: 745-9.
36. Loeliger EA, Esch B. The biological disappearance rate of pro thrombin, factors VII, and X from plasma in hypothyroidism, hyperthyroidism, and during fever. Thromb Diathes Haemorrh 1963; 10: 267-77.
37. Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med 1982; 97: 713-6.
38. Burggraaf J, Lalezari S, Emeis JJ, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 2001; 2: 153-60.
39. Erem C, Ersoz HO, Karti SS, Ukinc K, Hacihasanoglu A, Deger O, Telatar M. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 2002; 25: 345-50.
40. Raveh E, Cohen M, Shpitzer T, Feinmesser R. Carcinoma of the thyroid: a cause of hypercoagulability? Ear Nose Throat J 1995; 74: 110-2.